Cancer Biotherapy and Radiopharmaceuticals
Cancer Biotherapy and Radiopharmaceuticals is a multidisciplinary peer-reviewed journal covering all aspects of radiopharmaceutical research, as well as biotechnology. Cancer, Biotherapy, and Radiopharmaceuticals provides a high-profile platform for international original research papers, as well as comprehensive review articles, rapid communications, brief reports, protocols, technology reports, mini reviews, and rapid communications.
Cancer Biotherapy and Radiopharmaceuticals publishes original research addressing all aspects of radiopharmaceutical science. Contributions to this topic broadly includes the synthesis and characterization, in vitro studies, in vivo biodistribution and targeting validation studies, and in vivo research studies that support translational clinical studies of new targeted radiotracers, imaging agents, radiotherapeutic agents. Manuscripts on all of these aspects of radiopharmaceutical research with an emphasis on applications in the area of cancer research are appropriate.
Areas of focus can include, but are not limited to:
- PET and SPECT imaging
- Production, purification, validation of radionuclide use;
- Synthesis, characterization, and validation of radiopharmaceutical agents
- In vivo biological studies involving imaging, dosimetry, and therapeutic applications
- PET, SPECT, and other forms of radionuclide related imaging e.g. Cherenkov imaging
- Application and validation of targeted radiotherapeutic agents
Benefits of publishing in Cancer, Biotherapy, and Radiopharmaceuticals include:
• Rapid, authoritative peer review that is trusted across the industry
• Open Access guarantees broadest visibility
• Retain copyright of your work with a CC BY license, the most liberal available
• Fully funder compliant, ensuring you meet all grant requirements
• Translation, editing, and research promotion services available
• Articles included in dynamic marketing campaigns to more than 100,000 engaged users
• Global media outreach for selected papers
Contributions will receive prompt and thorough peer review.
Please refer to our Instructions for Authors before submitting your manuscript for consideration.